Cancer Research

ThromboGenics Begins Preclinical Development Of Anti-VPAC Antibody For Thrombocytopenia

LEUVEN, Belgium, November 14 /PRNewswire/--- Key Research Findings Published in the Leading Medical Journal `Blood' Validate Drug Target ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular disease, announces today t ...

Article - Anna Ohlden - Nov 14 2007 - 1:43am

Treasure In The Junk: 'Selfish Parasites' Helped P53 Become A Master Gene Regulator

When ancient retroviruses slipped bits of their DNA into the primate genome millions of years ago, they successfully preserved their own genetic legacy. Today an estimated 8 percent of the human genetic code consists of endogenous retroviruses (ERVs)--the ...

Article - News Staff - Nov 14 2007 - 12:18pm

Xenomics Announces Issuance Of A US Patent That Covers Use Of Transrenal Nucleic Acid Technology For Infectious Disease Diagnost

NEW YORK, November 14 /PRNewswire/-- Xenomics, Inc. (the "Company") (OTC Pink Sheets: XNOM; FWB: XE7) a developer of next-generation medical DNA diagnostic technologies, announced today issuance of its US patent "Methods for detection of nu ...

Article - Anna Ohlden - Nov 14 2007 - 1:03pm

Immunotherapy Boost: Stopping Cancerous Tumors Naturally

A multinational team of researchers writing in Nature has shown for the first time that the immune system can stop the growth of a cancerous tumor without actually killing it. Scientists have been working for years to use the immune system to eradicate can ...

Article - News Staff - Nov 18 2007 - 6:58pm

Genome Comparison Discovers 300 Previously Unknown Human Genes

Using supercomputers to compare portions of the human genome with those of other mammals, researchers at Cornell have discovered some 300 previously unidentified human genes, and found extensions of several hundred genes already known. The discovery is bas ...

Article - News Staff - Nov 20 2007 - 4:02pm

We Can Reprogram Skin Cells Into Stem Cells- So Do We Still Need Embryos?

This month we've witnessed the first-time success of two important stem cell research techniques in primate cells. Both techniques were previously developed in mice, but their success in humans and monkeys is important. Stem cells from cloned embryos ...

Article - Michael White - Nov 20 2007 - 11:57pm

Superbreads And The New Nutraceuticals

Nutraceuticals are used to create ‘functional foods’, the most commonly known of which are yogurts containing probiotic bacteria. However, many natural food products contain powerful ingredients that could be incorporated into food products to create funct ...

Article - News Staff - Nov 22 2007 - 12:30am

Prenatal Arsenic Exposure Detected In Newborns

MIT researchers have found that the children of mothers whose water supplies were contaminated with arsenic during their pregnancies harbored gene expression changes that may lead to cancer and other diseases later in life. In addition to establishing the ...

Article - News Staff - Nov 23 2007 - 1:30am

Anti-Cancer Drug Made From Soil Bacteria

Scientists from the Helmholtz Centre for Infection Research (HZI) have discovered a class of natural substances that are produced by soil bacteria and prevent somatic cells from dividing. After years of in-depth research, the US pharmaceuticals company Bri ...

Article - News Staff - Nov 25 2007 - 8:30am

Researchers Set New Chemical World Record

Chemists from the University of Delaware, in collaboration with a colleague at the University of Wisconsin, have set a new world record for the shortest chemical bond ever recorded between two metals, in this case, two atoms of chromium. The distance? A mi ...

Article - News Staff - Nov 24 2007 - 1:30pm